Purchases and Sales Made in Q4 2024 in Nektar Therapeutics (NKTR)
This table provides information about the institutional ownership of Nektar Therapeutics (NKTR) during Q4 2024. The information is specifically focused on institutions that hold shares of NEKTAR THERAPEUTICS.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.06M- 59.21% |
$950K - $1.53M
|
727K
$17.1M
|
|
|
Feb 14, 2025
Q4 2024
|
Shay Capital LLC
New York, NY |
SELL
|
- |
-1.24M- 77.92% |
$1.12M - $1.8M
|
352K
$8.27M
|
|
|
Feb 14, 2025
Q4 2024
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-2.75M- 29.26% |
$2.48M - $3.99M
|
6.65M
$156M
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-6.56M- 94.29% |
$5.9M - $9.51M
|
397K
$9.32M
|
|
|
Feb 14, 2025
Q4 2024
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-13.9M- 87.59% |
$12.6M - $20.2M
|
1.98M
$46.4M
|